CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Other events
- UPLOAD Other SEC-generated Letter
- 4 Gift Director gave 71,890 shares (gift)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 1,100,000 shares at $180.50 ($198,550,000)
- SC 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- 8-K Event Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Other events
- 8-K Event Agreement ended
- 8-K Event Results of operations
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Open-market sale SVP, General Counsel sold 791 shares at $216.26 ($171,059)
Page 23 of 64 · 1,278 filings